Lactobacillus gasseri SBT2055
Selected indexed studies
- Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model. (J Dairy Sci, 2019) [PMID:30471910]
- Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet. (J Nutr Sci, 2016) [PMID:27293560]
- Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. (Microbiol Immunol, 2006) [PMID:17116981]
_Worker-drafted node — pending editorial review._
Connections
Lactobacillus gasseri SBT2055 helps
Sources
- Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model. (2019) pubmed
- Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet. (2016) pubmed
- Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. (2006) pubmed
- Lactobacillus gasseri SBT2055 reduces infection by and colonization of Campylobacter jejuni. (2014) pubmed
- Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease. (2017) pubmed
- Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice. (2015) pubmed
- Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure. (2016) pubmed
- Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. (2014) pubmed
- In vitro investigation of molecules involved in Lactobacillus gasseri SBT2055 adhesion to host intestinal tract components. (2016) pubmed
- Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. (2014) pubmed